CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY,volume 6,issue 2  (05-2015)

Period of time： 2015年2期

Publisher： John Wiley & Sons Inc

Founded in： 2010

Total resources： 15

E-ISSN： 1759-1961|6|2

ISSN： 1759-1961

Subject： O Mathematical Sciences and Chemical

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY,volume 6,issue 2

Menu

Cover Image

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY,volume 6,issue 2 , Vol. 6, Iss. 2, 2015-05 , pp. i-i

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Accumulating knowledge of the barrier system in the central and peripheral nervous system: What's next?

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY,volume 6,issue 2 , Vol. 6, Iss. 2, 2015-05 , pp. 109-110

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY,volume 6,issue 2 , Vol. 6, Iss. 2, 2015-05 , pp. 111-112

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Reconstruction magnetic resonance neurography clearly shows distribution of nerve enlargement in chronic inflammatory demyelinating polyneuropathy

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY,volume 6,issue 2 , Vol. 6, Iss. 2, 2015-05 , pp. 113-113

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Glycoarray: A savior in an arduous sea?

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY,volume 6,issue 2 , Vol. 6, Iss. 2, 2015-05 , pp. 114-115

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Amyloid‐β hypothesis in Alzheimer's disease and neurotoxicity of oligomeric amyloid through glial cells

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY,volume 6,issue 2 , Vol. 6, Iss. 2, 2015-05 , pp. 116-117

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

How should we use calcineurin inhibitors in myasthenia gravis?

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY,volume 6,issue 2 , Vol. 6, Iss. 2, 2015-05 , pp. 118-119

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Immune cell gateways in the central nervous system regulated by regional neural stimulations

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY,volume 6,issue 2 , Vol. 6, Iss. 2, 2015-05 , pp. 120-128

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Blood–brain barrier: A novel therapeutic target in multiple sclerosis

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY,volume 6,issue 2 , Vol. 6, Iss. 2, 2015-05 , pp. 129-138

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Breakdown of blood‐nerve barrier in immune‐mediated neuropathy

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY,volume 6,issue 2 , Vol. 6, Iss. 2, 2015-05 , pp. 139-148

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Previous 1 2 3 Next Display item(s) per page Total 23 item(s)